Daily Trades

Rumors of a takeover have surrounded Shockwave for years. This cardiovascular device maker would make a great fit for Johnson & Johnson, Medtronic or Boston Scientific.
Rumors of a takeover have surrounded Shockwave for years. This cardiovascular device maker would make a great fit for Johnson & Johnson, Medtronic or Boston Scientific.
It’s been a tough couple of weeks for markets. That’s been especially true of small-cap stocks.
On March 1st, we recommended Seagen (SYM: SGEN) at $179.90 a share.
I’m recommending shares of software maker New Relic, Inc (SYM: NEWR) here at $83.84 a share.
A lot of folks have asked my whether it’s time to take profits in Seagen (SYM: SGEN).
Just a quick update this morning. Shares of Seagen, Inc (SYM: SGEN) were bought by Pfizer at $229 per share in cash.
I’m sending this out a day early. I’m recommending shares of Seagen, Inc (SYM: SGEN) here at $179.90 a share.

deal of the month

best growth stocks

Alliance

Bundle package – lifetime subscriptions for all products

Categories

Recent posts

Tags

Connect with Us

Rumors of a takeover have surrounded Shockwave for years. This cardiovascular device maker would make a great fit for Johnson & Johnson, Medtronic or Boston Scientific.
Rumors of a takeover have surrounded Shockwave for years. This cardiovascular device maker would make a great fit for Johnson & Johnson, Medtronic or Boston Scientific.
It’s been a tough couple of weeks for markets. That’s been especially true of small-cap stocks.
On March 1st, we recommended Seagen (SYM: SGEN) at $179.90 a share.
I’m recommending shares of software maker New Relic, Inc (SYM: NEWR) here at $83.84 a share.
A lot of folks have asked my whether it’s time to take profits in Seagen (SYM: SGEN).
Just a quick update this morning. Shares of Seagen, Inc (SYM: SGEN) were bought by Pfizer at $229 per share in cash.
I’m sending this out a day early. I’m recommending shares of Seagen, Inc (SYM: SGEN) here at $179.90 a share.

Get FREE Daily Stock Tips

Join and receive market insider stock picks, trade alerts and unique investing insights
This field is for validation purposes and should be left unchanged.
By clicking the "Subscribe" button you are accepting our Terms of Use and Privacy Policy.

Join Waitlist

We’re sorry, but due to the popularity of our services, we have reached our max number of subscribers and are not currently accepting more. If spots become available, we will be sure to contact you. Please join the waitlist below.
Thank You!

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.